Rob Ball
President & CEO
Mr. Ball most recently served at Tornier as Global Vice President, Research and Development from 2006 through 2013. During this time, Tornier grew from approximately $70M to $300M in annual revenues, meaningfully through organic growth of new products. Rob had prior roles leading R&D at Kinetikos Medical Inc (acquired by Integra Life Sciences), DePuy-Synthes, and in the automotive industry. Rob holds a BSME and MSME from Kettering University and holds over 30 issued or pending patents.
Don Running
VP R&D
Mr. Running has worked 24 years in the orthopedic industry serving in various C-level and executive R&D, Marketing and Business Development roles at both large corporations and start-ups including Depuy-Synthes, Biomet, DVO, and Genesis Innovation Group. Don co-founded DVO–Extremity Solutions LLC, which was sold to Tornier, Inc. in 2007. Don has a BSME from Wright State University and MSME from the University of Cincinnati and holds 13 issued and pending patents.
Genesis Innovation Group is a technology-driven firm, focused on the orthopedic space. Rather than focusing on a particular technology, Genesis is driven by the creation of value by identifying and understanding gaps in the orthopedic marketplace that provide opportunities where new technologies can improve the circumstances for all stakeholders in the care stream.
With the belief that success depends on partnerships built on transparency and humility, Genesis is built on partnerships between accomplished and successful surgeons, commercial entities, and engineers.
Genesis is more than an R&D consulting firm. It’s strategy most commonly includes a deep engagement (and self-financing) which drives partnerships toward shared objectives, creating an ideal win/win relationship.